FIELD: medicine, pharmaceutics.
SUBSTANCE: application of composition is proposed, which includes efficient amount of trans-clomiphene or its pharmaceutically acceptable salt, solvate and unnecessarily pharmaceutically acceptable dissolvents, adjuvants, carriers or excipients to produce medicinal agent for treatment of sterility in men with secondary hypogonadism.
EFFECT: composition considerably and durably increases both level of testosterone and luteinising hormone, as well as follicle-stimulating hormone, which stimulates spermatogenesis.
6 cl, 7 dwg, 3 ex, 1 tbl
Authors
Dates
2010-11-27—Published
2006-02-03—Filed